Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Registration - Consultant

NOVARTIS PHARMACEUTICALS CANADA INC / NOVARTIS PHARMA CANADA INC / VICTOR LITTLE, Consultant

Registration Information

Client name: NOVARTIS PHARMACEUTICALS CANADA INC / NOVARTIS PHARMA CANADA INC
Lobbyist name: VICTOR LITTLE, Consultant
Initial registration start date: 1998-08-10
Registration status: Inactive
Registration Number: 778334-1279

Version 1 of 1 (1998-08-10 to 2005-06-10)

Version 1 of 1 (1998-08-10 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: VICTOR LITTLE    Lobbyist business address
Consulting firm: VICTOR LITTLE & ASSOCIATES
2446 BANK STREET
OTTAWA, ON  K1V 1A8
Canada
Position: PRESIDENT
Telephone number: 613-720-7866  
Fax number: 613-739-1276  
 
Former public office holder: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: NOVARTIS PHARMACEUTICALS CANADA INC / NOVARTIS PHARMA CANADA INC
385 BOUL BOUCHARD
DORVAL, QC  H9S 1A9
Canada
Telephone number: 514-631-6775
Fax number: 514-631-7889  
 
Client Representative: JEAN-PAUL BEDARD
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program MONITOR & REVIEW HEALTH LEGISLATION AND POLICY [ PHARMACEUTICALS, DRUGS]




Date Modified: